Avalo Therapeutics Cash Flow Statement (2014-2026) | AVTX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
0.07M0.08M-0.07M-9.96M-8.19M-5.23M-8.17M-121.29M98.46M23.04M-35.34M-13.15M-20.77M-30.62M-13.72M-19.63M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
3.07M1.76M1.89M5.31M0.67M0.73M0.84M0.85M0.89M0.95M0.78M0.63M-0.63M0.51M8.60M-8.60M0.78M
Deferred Taxes (Quarter)
0.01M0.01M-0.06M0.01M0.01M0.01M0.01M0.01M0.01M0.01M-0.01M0.01M0.01M-0.01M0.11M0.01M0.02M0.01M0.13M0.01M
Gains from Investment Securities (Quarter)
1,700.00M79.28M-112.05M-36.02M135.57M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)
-19.19M-16.29M-17.10M-16.07M-12.47M5.73M-3.94M-10.05M-11.03M-6.84M-2.77M-6.20M-16.28M-11.53M-15.04M-9.46M-11.34M-16.41M-14.29M-17.70M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.10M0.34M0.35M0.35M0.34M0.35M0.35M0.35M0.35M0.90M0.15M0.35M0.20M0.11M
Depreciation & Amortization (CF) (Quarter)
0.46M0.46M0.29M0.07M0.03M0.03M0.04M0.03M0.04M0.04M0.04M0.03M0.03M0.03M0.07M0.14M0.13M0.06M0.02M0.02M
Change in Working Capital
Change in Receivables (Quarter)
0.99M-2.69M-0.38M-0.12M-0.39M-0.54M0.04M-0.04M
Change in Inventory (Quarter)
0.02M-0.00M0.02M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.02M
Change in Account Payables (Quarter)
-9.66M1.32M-0.20M0.39M-1.59M-0.72M1.44M2.68M-4.81M0.04M-0.34M0.47M-0.26M1.16M-1.53M0.40M1.69M-1.89M-0.34M0.22M
Change in Accured Expenses (Quarter)
3.19M-2.31M0.65M-2.29M-1.25M0.39M-0.49M-4.94M-0.69M-2.46M-0.96M-1.65M0.40M-0.86M1.00M-1.70M1.99M1.02M5.35M-1.50M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
0.44M-0.35M0.02M-0.11M0.09M-0.09M
Investing Activities
Capital Expenditures (Quarter)
1.98M-1.00M0.06M-0.06M0.10M0.16M
Sales of Property, Plant and Equipment (Quarter)
0.03M
Acquisitions (Quarter)
0.36M
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)
21.50M25.50M
Cash from Investing Activities (Quarter)
-0.08M-0.01M-0.06M-0.04M-0.13M0.36M-70.86M-13.26M2.40M25.50M
Financing Activities
Other financing activities (Quarter)
0.21M0.16M0.05M0.07M-0.07M108.10M7.53M142.70M0.04M-0.04M2.18M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
15.00M-14.81M6.00M
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
Net Equity Issued and Repurchased (Quarter)
25.94M
Misc.
Cash from Financing Activities (Quarter)
21.22M47.64M0.08M-14.78M0.08M13.75M0.60M10.70M0.00M108.61M-0.47M67.71M-0.47M14.37M0.69M1.40M
Change in Cash (Quarter)
2.03M31.27M-17.03M-16.07M-27.31M5.69M-3.86M3.56M-10.43M3.86M-2.77M102.77M-16.75M-11.53M52.66M-9.46M-82.72M-15.26M-11.16M9.21M
Free Cash Flow (Quarter)
-19.19M-18.27M-16.10M-16.07M-12.53M5.78M-4.04M-10.21M-11.03M-6.84M-2.77M-6.20M-16.28M-11.53M-15.04M-9.46M-11.34M-16.41M-14.29M-17.70M
Net Cash Flow (Quarter)
2.03M31.27M-17.03M-16.07M-27.31M5.69M-3.86M3.56M-10.43M3.86M-2.77M102.77M-16.75M-11.53M52.66M-9.46M-82.67M-15.30M-11.20M9.20M